Cargando…

Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration

The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hydrophilic/lipophilic emulsions and liposomes. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochiuz, Lacramioara, Grigoras, Cristian, Popa, Marcel, Stoleriu, Iulian, Munteanu, Corneliu, Timofte, Daniel, Profire, Lenuta, Grigoras, Anca Giorgiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272979/
https://www.ncbi.nlm.nih.gov/pubmed/27367664
http://dx.doi.org/10.3390/molecules21070858
_version_ 1783377278631149568
author Ochiuz, Lacramioara
Grigoras, Cristian
Popa, Marcel
Stoleriu, Iulian
Munteanu, Corneliu
Timofte, Daniel
Profire, Lenuta
Grigoras, Anca Giorgiana
author_facet Ochiuz, Lacramioara
Grigoras, Cristian
Popa, Marcel
Stoleriu, Iulian
Munteanu, Corneliu
Timofte, Daniel
Profire, Lenuta
Grigoras, Anca Giorgiana
author_sort Ochiuz, Lacramioara
collection PubMed
description The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hydrophilic/lipophilic emulsions and liposomes. In the current study, we present our most recent advances in the preparation of alendronate (AL)-loaded SLPs prepared by hot homogenization and ultrasonication using various ratios of a self-emulsifying lipidic mixture of Compritol 888, Gelucire 44/14, and Cremophor A 25. The prepared AL-loaded SLPs were investigated for their physicochemical, morphological and structural characteristics by dynamic light scattering, differential scanning calorimetry, thermogravimetric and powder X-ray diffraction analysis, infrared spectroscopy, optical and scanning electron microscopy. Entrapment efficacy and actual drug content were assessed by a validated HPLC method. In vitro dissolution tests performed in simulated gastro-intestinal fluids and phosphate buffer solution pH 7.4 revealed a prolonged release of AL of 70 h. Additionally, release kinetics analysis showed that both in simulated gastrointestinal fluids and in phosphate buffer solution, AL is released from SLPs based on equal ratios of lipid excipients following zero-order kinetics, which characterizes prolonged-release drug systems.
format Online
Article
Text
id pubmed-6272979
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62729792018-12-28 Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration Ochiuz, Lacramioara Grigoras, Cristian Popa, Marcel Stoleriu, Iulian Munteanu, Corneliu Timofte, Daniel Profire, Lenuta Grigoras, Anca Giorgiana Molecules Article The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hydrophilic/lipophilic emulsions and liposomes. In the current study, we present our most recent advances in the preparation of alendronate (AL)-loaded SLPs prepared by hot homogenization and ultrasonication using various ratios of a self-emulsifying lipidic mixture of Compritol 888, Gelucire 44/14, and Cremophor A 25. The prepared AL-loaded SLPs were investigated for their physicochemical, morphological and structural characteristics by dynamic light scattering, differential scanning calorimetry, thermogravimetric and powder X-ray diffraction analysis, infrared spectroscopy, optical and scanning electron microscopy. Entrapment efficacy and actual drug content were assessed by a validated HPLC method. In vitro dissolution tests performed in simulated gastro-intestinal fluids and phosphate buffer solution pH 7.4 revealed a prolonged release of AL of 70 h. Additionally, release kinetics analysis showed that both in simulated gastrointestinal fluids and in phosphate buffer solution, AL is released from SLPs based on equal ratios of lipid excipients following zero-order kinetics, which characterizes prolonged-release drug systems. MDPI 2016-06-29 /pmc/articles/PMC6272979/ /pubmed/27367664 http://dx.doi.org/10.3390/molecules21070858 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ochiuz, Lacramioara
Grigoras, Cristian
Popa, Marcel
Stoleriu, Iulian
Munteanu, Corneliu
Timofte, Daniel
Profire, Lenuta
Grigoras, Anca Giorgiana
Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
title Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
title_full Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
title_fullStr Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
title_full_unstemmed Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
title_short Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
title_sort alendronate-loaded modified drug delivery lipid particles intended for improved oral and topical administration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272979/
https://www.ncbi.nlm.nih.gov/pubmed/27367664
http://dx.doi.org/10.3390/molecules21070858
work_keys_str_mv AT ochiuzlacramioara alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration
AT grigorascristian alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration
AT popamarcel alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration
AT stoleriuiulian alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration
AT munteanucorneliu alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration
AT timoftedaniel alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration
AT profirelenuta alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration
AT grigorasancagiorgiana alendronateloadedmodifieddrugdeliverylipidparticlesintendedforimprovedoralandtopicaladministration